Applications for Leave

Decision Information

Decision Content

No. 39530     

 

 

July 8, 2021

 

Le 8 juillet 2021

 

 

 

BETWEEN:

Amgen Inc. and Amgen Canada Inc.

Applicants

- and -

Pfizer Canada ULC

Respondent

 

ENTRE :

Amgen Inc. et Amgen Canada Inc.

Demanderesses

- et -

Pfizer Canada SRI

Intimée

 

 

 

JUDGMENT

 

The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-122-20, 2020 FCA 188, dated November 3, 2020, is dismissed with costs.

 

 

 

JUGEMENT

 

La demande d’autorisation d’appel de l’arrêt de la Cour d’appel fédérale, numéro A-122-20, 2020 CAF 188, daté du 3 novembre 2020, est rejetée avec dépens.

 

 

 

 

J.S.C.C.

J.C.S.C.

 

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.